213 related articles for article (PubMed ID: 24831216)
1. Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy.
Longhi S; Guidalotti PL; Quarta CC; Gagliardi C; Milandri A; Lorenzini M; Potena L; Leone O; Bartolomei I; Pastorelli F; Salvi F; Rapezzi C
JACC Cardiovasc Imaging; 2014 May; 7(5):531-2. PubMed ID: 24831216
[No Abstract] [Full Text] [Related]
2. High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathy.
Quarta CC; Obici L; Guidalotti PL; Pieroni M; Longhi S; Perlini S; Verga L; Merlini G; Rapezzi C
Amyloid; 2013 Mar; 20(1):48-51. PubMed ID: 23231421
[TBL] [Abstract][Full Text] [Related]
3. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
[TBL] [Abstract][Full Text] [Related]
4. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
[TBL] [Abstract][Full Text] [Related]
5. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
[TBL] [Abstract][Full Text] [Related]
7. DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker.
Scully PR; Morris E; Patel KP; Treibel TA; Burniston M; Klotz E; Newton JD; Sabharwal N; Kelion A; Manisty C; Kennon S; Ozkor M; Mullen M; Hartman N; Elliott PM; Pugliese F; Hawkins PN; Moon JC; Menezes LJ
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1353-1363. PubMed ID: 32498921
[TBL] [Abstract][Full Text] [Related]
8. Cardiac scintigraphy with
de Haro-Del Moral FJ; Pubul-Núñez V; Casáns-Tormo I; Jiménez-Heffernan A; Ruano-Pérez R
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):254-266. PubMed ID: 32513587
[TBL] [Abstract][Full Text] [Related]
9. Early-phase myocardial uptake intensity of
Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
[TBL] [Abstract][Full Text] [Related]
10. Quantitative
Caobelli F; Braun M; Haaf P; Wild D; Zellweger MJ
J Nucl Cardiol; 2020 Oct; 27(5):1456-1463. PubMed ID: 31538322
[TBL] [Abstract][Full Text] [Related]
11. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
[TBL] [Abstract][Full Text] [Related]
12. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
Chen W; Ton VK; Dilsizian V
Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
[TBL] [Abstract][Full Text] [Related]
13. Letter to the editor concerning "Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?".
Yu AL; Tsai CH; Cheng MF; Lin YH
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2161-2162. PubMed ID: 38653815
[No Abstract] [Full Text] [Related]
14. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers.
Piekarski E; Chequer R; Algalarrondo V; Eliahou L; Mahida B; Vigne J; Adams D; Slama MS; Le Guludec D; Rouzet F
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1108-1118. PubMed ID: 29511839
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy.
Puille M; Altland K; Linke RP; Steen-Müller MK; Kiett R; Steiner D; Bauer R
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):376-9. PubMed ID: 12002714
[TBL] [Abstract][Full Text] [Related]
16. Can
Haq M; Pawar S; Berk JL; Miller EJ; Ruberg FL
JACC Cardiovasc Imaging; 2017 Jun; 10(6):713-714. PubMed ID: 27568122
[No Abstract] [Full Text] [Related]
17. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
[TBL] [Abstract][Full Text] [Related]
18. Transthyretin cardiac amyloid and aortic stenosis in the elderly, the role of nuclear imaging.
Merli E; Giudice ED; Antonopoulos A; Amadei G; Varani E
Int J Cardiovasc Imaging; 2017 Jun; 33(6):947-949. PubMed ID: 28155044
[No Abstract] [Full Text] [Related]
19. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
[TBL] [Abstract][Full Text] [Related]
20. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
